SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2026 / Cilt: 46 Sayı: 2

Thiol – Disulphide Homeostasis in Polycythemia Vera

Aysun Şentürk Yıkılmaz0000-0001-5281-5955
Şule Mine Bakanay0000-0003-3941-0368
Sema Akinci0000-0003-4237-3342
Senem Maral0000-0003-4766-1861
Fuad Mustafayev
Murat Alisik0000-0003-0434-3206
Özcan Erel0000-0002-2996-3236
İmdat Dilek
Pages
315–320
Publication Date
2019-06-11
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms, regulation of transcription factors and enzymatic activities, signal transduction and regulation of proliferation rate, apoptosis and detoxification and antioxidant protective mechanism. 

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms, regulation of transcription factors and enzymatic activities, signal transduction and regulation of proliferation rate, apoptosis and detoxification and antioxidant protective mechanism. 
📊
Key Findings & Data:Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms, regulation of transcription factors and enzymatic activities, signal transduction and regulation of proliferation rate, apoptosis and detoxification and antioxidant protective mechanism. 
💡
Conclusion & Impact:Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms, regulation of transcription factors and enzymatic activities, signal transduction and regulation of proliferation rate, apoptosis and detoxification and antioxidant protective mechanism. 
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Polycythemia Vera · thiol · disulphide bonds

Özet

Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms, regulation of transcription factors and enzymatic activities, signal transduction and regulation of proliferation rate, apoptosis and detoxification and antioxidant protective mechanism. 

🔖

Cite This Article

Yıkılmaz, A. Ş., Bakanay, Ş. M., Akinci, S., Maral, S., Mustafayev, F., Alisik, M., Erel, Ö., Dilek, İ. (2019). Thiol – Disulphide Homeostasis in Polycythemia Vera. Dicle Tıp Dergisi, Cilt: 46 Sayı: 2, 315–320. https://doi.org/10.5798/dicletip.574893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Ruben A. Mesa, Murray N. Silverstein, et all. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol. 1999; 61: 10-5.
  2. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014; 47: 326- 32.
  3. Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013; 65: 244-53.
  4. Kundi H, Erel Ö, Balun A, et all. Association of thiol/disulfide ratio with syntax score in patients with NSTEMI. Scand Cardiovasc J. 2015; 49: 95-100.
  5. Li W, Busu C, Circu ML, Aw TY. Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis. Int J Cell Biol. 2012: 434971.
  6. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal. 2009; 11: 3013-69.
  7. Kundi H, Ates I, Kiziltunc E, et all. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015; 33: 1567-71.
  8. Ateş İ, Ozkayar N, Altay M, et all. Is disulphide/thiol ratio related to blood pressure in masked hypertension? Clin Exp Hypertens. 2016; 38: 150-4
  9. Ates I, Kaplan M, Yuksel M, et all. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016; 51: 47-51.
  10. Korkmaz V, Kurdoglu Z, Alisik M, et all. Impairment of thiol-disulphide homeostasis in preeclampsia. J Matern Fetal Neonatal Med. 2016; 3: 1-6
  11. Bektas H, Vural G, Gumusyayla S et all. Dynamic thiol-disulphide homeostasis in acute ischemic stroke patients. Acta Neurol Belg. 2016; 116: 489-94.
  12. Prabhu A, Sarcar B, Kahali S, et all. Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res. 2014; 74: 787–96.
  13. Kirlin WG, Cai J, Thompson SA, et all. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med. 1999; 27: 1208–18.
  14. Nkabyo YS, Ziegler TR, Gu LH, et all. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: 1352–9.
  15. Michiels J.J.,Berneman Z.,Schroyens W, et all. Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond, Acta Haematologica. 2015; 133: 36-51.
  16. Cao HC, Lin J, Qian J, et all. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis. J Clin Lab Anal. 2011; 25: 300-4. doi: 10.1002/jcla.20474.
  17. Andersen CL, Bjørn ME, McMullin MF, et all l. Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat. Leuk Res. 2014; 38: 816-21.
  18. Bjørn ME, Andersen CL, Jensen MK, et all. Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state. Eur J Haematol. 2014; 93: 224-8.
  19. Klampfl T, Gisslinger H, Harutyunyan AS, et all. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369: 2379-90.
  20. Bruchova H, Yoon D, Agarwal AM, et all. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation. Blood Cells Mol Dis. 2009; 43: 81-7.
  21. Laubach JP, Fu P, Jiang X, et all. Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation. Exp Hematol. 2009; 37: 1411-22.
  22. Blume KG, Paniker NV, Beutler E. Enzymes of glutathione synthesis in patients with myeloproliferative disorders. Clin Chim Acta. 1973; 45: 281- 5.
  23. Ates I, Kaplan M, Yuksel M, et all. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016; 1: 47-51.
  24. Yıldırım F, Sermetow K, Aycicek A, et all. Increased oxidative stress in preschool children exposed to passive smoking. J Pediatr (Rio J). 2011; 87: 523-8.
  25. Ozler S, Oztas E, Erel O, et al. Impact of Gestational Diabetes Mellitus and Maternal Obesity on Cord Blood Dynamic Thiol/Disulfide Homeostasis. Fetal Pediatr Pathol. 2017; 36: 8-15. doi: 10.1080/15513815.2016.1223237.
  26. Babaoglu E, Kilic H, Hezer H, et all. Comparison of thiol/disulphide homeostasis parameters in patients with COPD, asthma and ACOS. Eur Rev Med Pharmacol Sci. 2016; 20: 1537-43.
  27. Hanikoglu F, Hanikoglu A, Kucuksayan E, et al. Dynamic Thiol/Disulphide Homeostasis Before and After Radical Prostatectomy in Patients with Prostate Cancer. Free Radic Res. 2016; 50: S79-S84
  28. Dirican N, Dirican A, Sen O, et al. Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Rep. 2016; 21: 197-203.
  29. Guney T, Kanat IF, Alkan A, et al. Assessment of serum thiol/disulfide homeostasis in multiple myeloma patients by a new method. Redox Report. 2017;22: 246- 51. doi: 10.1080/13510002.2016.1180100.
  30. Aldemir M, Karaguzel E, Okulu E, et all. Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma. Cent European J Urol. 2015; 68: 415-20.